Biotech CEO podcast with Huahui CSO Li Wenhui
Citeline Podcasts - A podcast by Citeline
Categories:
Huahui Health CSO Li Wenhui sits down with Scrip in the office to discuss many of the key issues such as, how he views antivirals development post-COVID? how the company’s hepatitis drugs differentiated from others? Given the current antivirals from Gilead among others, why Li believed that the antiviral development remains vital?